0.3318 USD
-0.01 (-2.75%)
At close: Jan 30, 2026
0.3479 USD
+0.02 (+4.85%)
After Hours: 1/30/2026, 8:00:02 PM
FBLG gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. FBLG has a bad profitability rating. Also its financial health evaluation is rather negative. FBLG does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- FBLG had negative earnings in the past year.
- FBLG had a negative operating cash flow in the past year.
1.2 Ratios
- The Return On Assets of FBLG (-211.59%) is worse than 88.38% of its industry peers.
- FBLG has a worse Return On Equity (-14800.80%) than 81.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -211.59% | ||
| ROE | -14800.8% | ||
| ROIC | N/A |
ROA(3y)-111.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for FBLG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, FBLG has more shares outstanding
- FBLG has a worse debt/assets ratio than last year.
2.2 Solvency
- FBLG has an Altman-Z score of -13.45. This is a bad value and indicates that FBLG is not financially healthy and even has some risk of bankruptcy.
- FBLG's Altman-Z score of -13.45 is on the low side compared to the rest of the industry. FBLG is outperformed by 77.90% of its industry peers.
- FBLG has a Debt/Equity ratio of 36.58. This is a high value indicating a heavy dependency on external financing.
- FBLG's Debt to Equity ratio of 36.58 is on the low side compared to the rest of the industry. FBLG is outperformed by 81.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 36.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.45 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.78 indicates that FBLG may have some problems paying its short term obligations.
- FBLG has a worse Current ratio (0.78) than 87.62% of its industry peers.
- FBLG has a Quick Ratio of 0.78. This is a bad value and indicates that FBLG is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.78, FBLG is doing worse than 87.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.78 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
- FBLG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.73%, which is quite impressive.
EPS 1Y (TTM)45.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, FBLG will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.84% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-39.21%
EPS Next 2Y-3.37%
EPS Next 3Y-5.86%
EPS Next 5Y-13.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- FBLG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year FBLG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- FBLG's earnings are expected to decrease with -5.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.37%
EPS Next 3Y-5.86%
5. Dividend
5.1 Amount
- No dividends for FBLG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FIBROBIOLOGICS INC / FBLG FAQ
Can you provide the ChartMill fundamental rating for FIBROBIOLOGICS INC?
ChartMill assigns a fundamental rating of 0 / 10 to FBLG.
What is the valuation status of FIBROBIOLOGICS INC (FBLG) stock?
ChartMill assigns a valuation rating of 0 / 10 to FIBROBIOLOGICS INC (FBLG). This can be considered as Overvalued.
What is the profitability of FBLG stock?
FIBROBIOLOGICS INC (FBLG) has a profitability rating of 0 / 10.
What is the earnings growth outlook for FIBROBIOLOGICS INC?
The Earnings per Share (EPS) of FIBROBIOLOGICS INC (FBLG) is expected to decline by -39.21% in the next year.